Violation Tracker Individual Record
Date:September 29, 2008
Offense Group:healthcare-related offenses
Primary Offense:off-label or unapproved promotion of medical products
Secondary Offense:False Claims Act and related
Cephalon Inc. agreed to enter a criminal plea and pay a $50 million criminal penalty and a $375 million civil settlement to resolve claims that it marketed three drugs for uses not approved by the Food and Drug Administration.
Level of Government:federal
Action Type:agency action
Agency:Justice Department Civil Division
Civil or Criminal Case:civil and criminal
HQ Country of Parent:Israel
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source of Data:
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.